BMA is trading 2.4% up now at $91.84, rebounding after yesterday’s 3.1% drop. There are no fresh company-specific headlines, earnings releases, or analyst calls dated July 2, 2026 explaining the move. Broader U.S. equity indices are modestly higher, which may be providing some support, while recent technical commentary highlighted a potential trend reversal setup for BMA, but that analysis is not tied specifically to today’s session.